H M Kravitz1, L L Schott2, H Joffe3, J M Cyranowski4, J T Bromberger5. 1. Departments of Psychiatry and Preventive Medicine,Rush University Medical Center,Chicago, IL,USA. 2. Department of Epidemiology, Graduate School of Public Health,University of Pittsburgh,Pittsburgh, PA,USA. 3. Brigham and Women's Hospital,Harvard Medical School,Boston, MA,USA. 4. Departments of Psychology and Psychiatry,University of Pittsburgh and University of Pittsburgh Medical Center,Pittsburgh, PA,USA. 5. Departments of Epidemiology and Psychiatry,University of Pittsburgh,Pittsburgh, PA,USA.
Abstract
BACKGROUND: In women, anxiety symptoms are common and increase during midlife, but little is known about whether these symptoms predict onsets of major depressive disorder (MDD) episodes. We examined whether anxiety symptoms are associated with subsequent episodes of MDD in midlife African-American and Caucasian women, and whether they confer a different risk for first versus recurrent MDD episodes. METHOD: A longitudinal analysis was conducted using 12 years of data from the Study of Women's Health Across the Nation (SWAN) Mental Health Study (MHS). The baseline sample comprised 425 Caucasian (n=278) and African American (n=147) community-dwelling women, aged 46.1±2.5 years. Anxiety symptoms measured annually using a self-report questionnaire were examined in relation to MDD episodes in the subsequent year, assessed with the SCID. Multivariable models were estimated with random effects logistic regression. RESULTS: Higher anxiety symptoms scores were associated with a significantly higher adjusted odds of developing an episode of MDD at the subsequent annual visit [odds ratio (OR) 1.47, p=0.01], specifically for a recurrent episode (OR 1.49, p=0.03) but non-significant for a first episode (OR 1.32, p=0.27). There were no significant racial effects in the association between anxiety symptoms and subsequent MDD episodes. CONCLUSIONS: Anxiety symptoms often precede MDD and may increase the vulnerability of midlife women to depressive episodes, particularly recurrences. Women with anxiety symptoms should be monitored clinically during the ensuing year for the development of an MDD episode.
BACKGROUND: In women, anxiety symptoms are common and increase during midlife, but little is known about whether these symptoms predict onsets of major depressive disorder (MDD) episodes. We examined whether anxiety symptoms are associated with subsequent episodes of MDD in midlife African-American and Caucasian women, and whether they confer a different risk for first versus recurrent MDD episodes. METHOD: A longitudinal analysis was conducted using 12 years of data from the Study of Women's Health Across the Nation (SWAN) Mental Health Study (MHS). The baseline sample comprised 425 Caucasian (n=278) and African American (n=147) community-dwelling women, aged 46.1±2.5 years. Anxiety symptoms measured annually using a self-report questionnaire were examined in relation to MDD episodes in the subsequent year, assessed with the SCID. Multivariable models were estimated with random effects logistic regression. RESULTS: Higher anxiety symptoms scores were associated with a significantly higher adjusted odds of developing an episode of MDD at the subsequent annual visit [odds ratio (OR) 1.47, p=0.01], specifically for a recurrent episode (OR 1.49, p=0.03) but non-significant for a first episode (OR 1.32, p=0.27). There were no significant racial effects in the association between anxiety symptoms and subsequent MDD episodes. CONCLUSIONS:Anxiety symptoms often precede MDD and may increase the vulnerability of midlife women to depressive episodes, particularly recurrences. Women with anxiety symptoms should be monitored clinically during the ensuing year for the development of an MDD episode.
Authors: Joyce T Bromberger; Laura L Schott; Howard M Kravitz; Maryfran Sowers; Nancy E Avis; Ellen B Gold; John F Randolph; Karen A Matthews Journal: Arch Gen Psychiatry Date: 2010-06
Authors: Joyce T Bromberger; Howard M Kravitz; Yuefang Chang; John F Randolph; Nancy E Avis; Ellen B Gold; Karen A Matthews Journal: Menopause Date: 2013-05 Impact factor: 2.953
Authors: William Coryell; Jess G Fiedorowicz; David Solomon; Andrew C Leon; John P Rice; Martin B Keller Journal: Br J Psychiatry Date: 2011-10-07 Impact factor: 9.319
Authors: Bernd Löwe; Oliver Decker; Stefanie Müller; Elmar Brähler; Dieter Schellberg; Wolfgang Herzog; Philipp Yorck Herzberg Journal: Med Care Date: 2008-03 Impact factor: 2.983
Authors: Rob V Bijl; Ron De Graaf; Anneloes Ravelli; Filip Smit; Wilma A M Vollebergh Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2002-08 Impact factor: 4.328
Authors: Howard M Kravitz; Imke Janssen; Joyce T Bromberger; Karen A Matthews; Martica H Hall; Kristine Ruppert; Hadine Joffe Journal: Curr Sleep Med Rep Date: 2017-08-05
Authors: Sandra M Meier; Liselotte Petersen; Manuel Mattheisen; Ole Mors; Preben B Mortensen; Thomas M Laursen Journal: Lancet Psychiatry Date: 2015-05-14 Impact factor: 27.083
Authors: Elżbieta Grochans; Małgorzata Szkup; Artur Kotwas; Jacek Kopeć; Beata Karakiewicz; Anna Jurczak Journal: Int J Environ Res Public Health Date: 2018-04-10 Impact factor: 3.390
Authors: Se Hee Min; Qing Yang; Se Won Min; Leila Ledbetter; Sharron L Docherty; Eun-Ok Im; Sharron Rushton Journal: Womens Health (Lond) Date: 2022 Jan-Dec